ATL-101 (Alizyme)

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameATL-101 (Alizyme)
Drug Alias NameAZM-128
ClassificationOther
Mechanisms of ActionIntercellular signaling peptides and proteins stimulants
TargetsIntercellular signaling peptides and proteins
Therapy Area/IndicationsMucositis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRowett Research Institute（THE）Alizyme
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlizymeRowett Research Institute（THE）
Active IndicationsN/A
Inactive IndicationsMucositis

Other Information

ATC CodeN/A
Related LinksN/A